News and Trends 23 Dec 2016
The 8 Biggest Biotech Medical Fails of 2016 in Europe
Although 2016 has brought plenty of good news in medical advances, biotech is an industry where failure is part of…
Eli Lilly
- Latest Posts
News and Trends 19 Dec 2016
Following Eli Lilly’s Failure, what’s Next in Alzheimer’s Treatments?
Hopes for an Alzheimer’s cure took a hit with Eli Lilly’s recent failure, but it’s not over yet. Probiodrug explains…
News and Trends 7 Nov 2016
Results from 45% of Clinical Trials are kept Secret
A new transparency study has identified Sanofi, Novartis and GSK as the companies that keep the most clinical trial results unreported.…
News and Trends 4 Apr 2016
Biotech Environment in 2016: Reverse Engineering the Ecosystem #BES2016
BIO-Europe Spring 2016 is starting off right away with the plenary opening session. The conference was about partnering, trends and…
ADVERTISEMENT
News and Trends 17 Mar 2016
A Relief for Migraines at last? The Biotech race for the Ultimate Cure
A Migraine is more than just a headache; it is a neurological disorder affecting a staggering 10% of the worldwide…
News and Trends 25 Jan 2016
Also Using PD-L1 Cancer Treatments to Attack Alzheimer’s Disease
What updates have occurred in the Neurodegenerative disease field as of late? New appointments by the Dementia Discovery Fund, which…
News and Trends 9 Nov 2015
This French Biotech has a ‘Super-Insulin’ up its Diabetes Sleeve
Human insulin produced in Bacteria is already a miracle for Diabetes...but sometimes, it’s not as efficient as it could be.…
News and Trends 16 Jul 2015
Immunocore Skyrocketed by Europe’s Largest Private Biotech Financing Ever
Immunocore Limited, just announced that it has secured a £205 million financing (€293 m) from private investors to push forward its T…
News and Trends 3 Jul 2015
Lilly Cooperates with Immunocore to Fight Skin Cancer
Eli Lilly expands its portfolio in immune-oncology therapies. This time, Immunocore's lead T cell receptor-based drug, IMCgp100 is tested in…
News and Trends 1 Jul 2015
Is Adocia & Eli Lilly’s treatment the new diabetes blockbuster?
Adocia and Eli Lilly completed an impressive Phase Ib clinical trial evaluating BioChaperone Lispro, a treatment designed to accelerate insulin…
ADVERTISEMENT
News and Trends 31 May 2015
AstraZeneca and Eli Lilly Combine their Innovative Drugs for Cancer Treatment
The big pharma companies Eli Lilly and AstraZeneca will combine two of their cancer drugs to make the perfect cocktail…
News and Trends 14 May 2015
Eli Lilly signs a €250M deal with BioNTech for new Cancer Immunotherapies
Using immunotherapy to treat cancer is one of the hottest trends in healthcare research right now. The latest collaboration in…
News and Trends 20 Dec 2014
French Biotech Start-up Adocia signs Massive €464M Diabetes Deal with Eli Lilly
The French biotechnology company Adocia entered into an alliance with the US Eli Lilly on the co-development of an ultra-fast…
News and Trends 16 Sep 2014
The first insulin biosimilar has been approved in Europe
The European Commission granted marketing authorisation to Eli Lilly and Company and Boehringer Ingelheim for the first insulin biosimilar glargine…
